NCT02565784View on ClinicalTrials.gov

Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 29, 2016

Study Completion Date

September 28, 2018

Conditions
Healthy Volunteers
Interventions
DEVICE

Restylane

Facial tissue augmentation

DEVICE

Perlane

Facial tissue augmentation

Trial Locations (2)

Unknown

Galderma Research Site, Kaohsiung City

Galderma Research Site, Taipei

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT02565784 - Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population | Biotech Hunter | Biotech Hunter